Posted by Gary Schwitzer in Disease mongering, Drug industry, FDA
The Wall Street Journal Health Blog published an interesting inside look of – as they put it – “how drug makers can try to lay the groundwork for sales well before a new therapy hits the market.”
The topic is premature ejaculation.
Some might call the methods “disease-mongering.”
At least on the Chicago Tribune’s website, this story appeared in the Health section – not the local business or feature section. It didn’t address most of the things we think are crucial in a health story.
“Brown fat” has ignited a grease fire of media hype in recent weeks.This WebMD story missed a good opportunity to smother the flames.
We reviewed this story and a competing AP story on these new fibroid studies. Read and compare.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2012 Health News Review
Add Comment
Disclaimer: I welcome comments but will delete those with any kind of product pitch, profanity, personal attacks or those from anyone who doesn’t list what appears to be an actual e-mail address. I will also end any thread of comments that are repetitive. Because I moderate comments, I can’t keep reacting to repeatedly inaccurate or unsubstantiated claims. We don't give medical advice so we won't respond to questions asking for it.